On March 27, 2020, Dr. Robin L. Smith notified the Board of Directors of Seelos Therapeutics, Inc. of her decision not to seek re-election to the Board at the Company's 2020 Annual Meeting of Stockholders ("2020 Annual Meeting"). Dr. Smith served as a Class III director of the Company and her service on the Board will cease when her current term expires at the 2020 Annual Meeting. Dr. Smith's decision not to stand for re-election at the 2020 Annual Meeting was not as a result of any disagreement with the Company or any matters relating to the Company's operations, policies or practices.